Gastroenterología y Hepatología (English Edition)

High persistence rate at one year- follow-up of subcutaneous vedolizumab at standard dose after switching endovenous vedolizumab, even in those previously intensified: Results of a Spanish multicentre observational study Laura Andrés; Marisa Iborra; Raquel Vicente; Lara Arias; Pilar Nos; Ana Royo-Esteban; Beatriz Sicilia;

Real-world clinical characteristics and therapeutic strategies in patients with moderate-to-severe inflammatory bowel disease in Argentina: Data from the RISE-AR study Pablo Andres Olivera; Domingo Balderramo; Juan Sebastian Lasa; Ignacio Zubiaurre; Gustavo Correa; Pablo Lubrano; Orlando Ruffinengo; Martin Yantorno; Astrid Rausch; Gisela Piñero; Andrea Bolomo; Carla Amigo; Jazmin El-Hakeh; Daiana Beatriz Leonardi; Laura Brion; Alicia Sambuelli;

Tofacitinib in the treatment of moderate to severe ulcerative colitis in Colombia: Real world experience Viviana Parra-Izquierdo; Juan Sebastián Frías-Ordoñez; Juan Ricardo Márquez; Fabián Juliao-Baños; Pablo Galindo; Carlos Cuadros; Carlos Rojas; Nelson Rojas; Oscar Ardila; German Tovar-Fierro; Rafael García-Duperly; Melquicedec Vargas; Cristian Flórez-Sarmiento;